The UK gummy market size was exhibited at USD 387.15 million in 2023 and is projected to hit around USD 1,214.29 million by 2033, growing at a CAGR of 12.11% during the forecast period 2024 to 2033.
Report Coverage | Details |
Market Size in 2024 | USD 434.03 Million |
Market Size by 2033 | USD 1,214.29 Million |
Growth Rate From 2024 to 2033 | CAGR of 12.11% |
Base Year | 2023 |
Forecast Period | 2024-2033 |
Segments Covered | Product, End-use, Ingredient, Distribution Channel |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Country scope | UK |
Key Companies Profiled | Amway Corp; Bayer AG; Chruch & Dwight Co. Inc.; Ernest Jackson & Co. Ltd.; Ion Labs Inc.; Pfizer Inc.; Reckitt Benckiser Group Plc; UK Gummy Company; Nature’s Bounty Inc.; Perrigo Co. |
Projected growth for this market can be attributed to extensive admiration of gummy supplements in the UK, rising awareness about elements utilised in the processed foods, mindful consumer behaviour concerning food and beverages, shifting tendencies causing preference towards nutraceuticals over pharmaceuticals, and growing prevalence of health intricacies such as cardiovascular diseases and diabetes among others.
The UK gummy market accounted for 3.98% of the global gummy market in 2023.
Features that mainly influence the growth of gummy market in the UK are growing inclinations towards improved lifestyle in terms of health, increased embracing of easy-to-consume foods and supplements, growing accessibility of diverse variants such as vegan and plant-based alternatives, increasing mindfulness about environmental accountabilities as customers, and novelty accompanied by massive product portfolio.
The ever-changing lifestyle of young population, draining and extended work hours followed by long travels, unceasing urbanisations has directed this population to situation where customers are more concerned about their health and food that they consume. This has led them to consumption of food, which is considered healthy, thoughtful addition of vitamins and minerals and melatonin as well in daily diets, increased consciousness about animal welfare and deliberate moves by producers to highlight their approach towards adoption of sustainable products that are made through cruelty free processes.
Vitamin-based gummy market accounted for 24.91% in the year 2023. Growing vitamin deficiencies is one of the main reasons behind the increasing use of vitamin-based gummies in the UK. Vitamins like D and B12, are becoming a problem area for many due to the changing lifestyles, the long working hours and other health related problems. The vitamin gummies are considered as one of the most convenient ways of vitamin intake and they are also provided by manufacturers in different kinds of shapes and colour to variety to it.
CBD/CBN-based gummy market is expected to grow at CAGR of 18.6% from 2024 to 2033. CBD/CBN, (Cannabidiol/Cannabinol) two of more than many other kinds of chemical constituents, which are found in the cannabis, plant naturally. The projected growth for this market is also been positively impacted by the increasing adoption of CBD/CBN-based gummies in treatments of chronic health conditions such as dementia.
Adult gummy market accounted for 79.63% in 2023. This can be attributed to presence of growing geriatric population in the country. In addition, prescription-based use of gummies have now become a thing in the market, which is assisting the increase in demands.
Kids gummy market in UK is expected to grow at CAGR of 14.9% from 2024 to 2033. This market has continuously been acquiring the greater market share each year is projected to reach unmatched growth patterns in approaching years.
The gelatin-based gummy market in the UK accounted for 68.0% in the year 2023. These are one of the most common gummies that are distributed widely by the manufacturing companies. The texture offering and cost-effective feature of these gummies generate greater demand through all sorts of market and distribution channels. Gummies like these, with gelatine as their prime ingredient, offer hard and chewy texture for users. This is one of the key reasons behind consumer’s inclination towards gelatine-based gummies.
The plant-based gelatin-substitute market in the country is expected to grow at CAGR of 14.4% from 2024-2033. In recent past, several cases about excessive consumption of the gelatine-based gummies have created the awareness about consequences associated with it. This has helped the plant-based substitute market to grow with greater pace.
The sales generated through offline distribution channel in UK gummy market accounted for 79.00% of the market size in 2023. This is mainly due to unparalleled distribution and availability of gummies through offline channels such as practitioners, hypermarkets, speciality store, supermarkets and most importantly local pharmacies. This approach offers increased brand visibility as well as enhanced market penetration for companies. This is easiest for makers to reach their consumers directly.
Sales of gummies through online channel is expected to grow at CAGR of 15.6% from 2024 to 2033. This can be attributed to slowly yet steadily growing popularity of online shopping experience. The online way of buying gummies is also considered as absolutely private and limited to knowledge of the buyer only.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the UK gummy market
Product
End-use
Ingredients
Distribution Channel
Chapter 1. Methodology and Scope
1.1. Market Segmentation& Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. UK gummy market Variables; Trends & Scope
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Sales/Retail Channel Analysis
3.2.2. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Industry Challenges
3.3.4. Industry Opportunities
3.4. Industry Analysis Tools - Porter’s Five Forces Analysis
3.5. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
4.1. Demographic Analysis
4.2. Consumer Trends & Preferences
4.3. Factors Influencing Buying Decisions
4.4. Consumer Product Adoption Trends
4.5. Observations & Recommendations
Chapter 5. UK gummy market: Product Estimates & Trend Analysis
5.1. Product Movement Analysis & Market Share, 2024 & 2033
5.2. UK Gummy Market Estimates & Forecast, By Product, 2021 to 2033 (USD Million)
5.2.1. Vitamins
5.2.1.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.2. Minerals
5.2.2.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.3. Carbohydrates
5.2.3.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.4. Omega Fatty Acids
5.2.4.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.5. Proteins & Amino Acids
5.2.5.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.6. Probiotics & Prebiotics
5.2.6.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.7. Dietary Fibbers
5.2.7.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.8. CBD/CBN
5.2.8.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.9. Psilocybin/Psychedelic Mushroom
5.2.9.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.10. Melatonin
5.2.10.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
5.2.11. Others
5.2.11.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
Chapter 6. UK Gummy Market: End-use Estimates & Trend Analysis
6.1. End-use Movement Analysis & Market Share, 2024 & 2033
6.2. UK Gummy Market Estimates & Forecast, By End-use, 2021 to 2033 (USD Million)
6.2.1. Adult
6.2.1.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
6.2.1.2. Men
6.2.1.2.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
6.2.1.3. Women
6.2.1.3.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
6.2.1.4. Pregnant Women
6.2.1.4.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
6.2.1.5. Geriatric
6.2.1.5.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
6.2.2. Kids
6.2.2.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
Chapter 7. UK Gummy Market: Ingredients Estimates & Trend Analysis
7.1. Ingredients Movement Analysis & Market Share, 2024 & 2033
7.2. UK Gummy Market Estimates & Forecast, By Ingredients, 2021 to 2033 (USD Million)
7.2.1. Gelatin
7.2.1.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
7.2.2. Plant-based Gelatin Substitute
7.2.2.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
Chapter 8. UK Gummy Market: Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel Movement Analysis & Market Share, 2024 & 2033
8.2. UK Gummy Market Estimates & Forecast, through distribution channel, 2021 to 2033 (USD Million)
8.2.1. Offline
8.2.1.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
8.2.1.2. Hypermarkets/Supermarkets
8.2.1.2.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
8.2.1.3. Pharmacies
8.2.1.3.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
8.2.1.4. Specialty Stores
8.2.1.4.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
8.2.1.5. Practitioner
8.2.1.5.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
8.2.1.6. Others
8.2.1.6.1. Market Estimates & Forecasts, 2021 to 2033 (USD Million)
Chapter 9. US Gummy Market - Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Overview
9.4. Financial Performance
9.5. Product Benchmarking
9.6. Strategic Initiatives
9.7. Company Market Positioning
9.8. Company Market Share Analysis, 2023 (%)
9.9. Company Heat Map Analysis
9.10. Strategy Mapping
9.11. Company Profiles
9.11.1. Amway Corp.
9.11.1.1. Company Overview
9.11.1.2. Financial Performance
9.11.1.3. Product Benchmarking
9.11.1.4. Strategic Initiatives
9.11.2. Bayer AG
9.11.2.1. Company Overview
9.11.2.2. Financial Performance
9.11.2.3. Product Benchmarking
9.11.2.4. Strategic Initiatives
9.11.3. Chruch & Dwight Co. Inc.
9.11.3.1. Company Overview
9.11.3.2. Financial Performance
9.11.3.3. Product Benchmarking
9.11.3.4. Strategic Initiatives
9.11.4. Ernest Jackson & Co. Ltd.
9.11.4.1. Company Overview
9.11.4.2. Financial Performance
9.11.4.3. Product Benchmarking
9.11.4.4. Strategic Initiatives
9.11.5. Ion Labs Inc.
9.11.5.1. Company Overview
9.11.5.2. Financial Performance
9.11.5.3. Product Benchmarking
9.11.5.4. Strategic Initiatives
9.11.6. Pfizer Inc.
9.11.6.1. Company Overview
9.11.6.2. Financial Performance
9.11.6.3. Product Benchmarking
9.11.6.4. Strategic Initiatives
9.11.7. Reckitt Benckiser Group PLC
9.11.7.1. Company Overview
9.11.7.2. Financial Performance
9.11.7.3. Product Benchmarking
9.11.7.4. Strategic Initiatives
9.11.8. UK Gummy Company
9.11.8.1. Company Overview
9.11.8.2. Financial Performance
9.11.8.3. Product Benchmarking
9.11.8.4. Strategic Initiatives
9.11.9. Nature’s Bounty Inc.
9.11.9.1. Company Overview
9.11.9.2. Financial Performance
9.11.9.3. Product Benchmarking
9.11.9.4. Strategic Initiatives
9.11.10. Perrigo Co.
9.11.10.1. Company Overview
9.11.10.2. Financial Performance
9.11.10.3. Product Benchmarking
9.11.10.4. Strategic Initiatives